ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag dengue culture immunology microbiology

Transmission electron microscope image of Zika virus particles
T Cell–Boosting Zika Vaccine Protects Mice from the Virus
Ruth Williams | May 12, 2021 | 4 min read
By avoiding the production of antibodies, something vaccines ordinarily induce, the immunization sidesteps the problem of antibody-dependent enhancement, which can amplify infection by a similar virus and is known to occur with dengue and Zika.
Viruses of the Human Body
Eric Delwart | Nov 1, 2016 | 10 min read
Some of our resident viruses may be beneficial.
Some Antibiotics Rev Up Host Immune Response to Viruses
Shawna Williams | Apr 9, 2018 | 4 min read
The antimicrobial drug neomycin protects mice from some viral infections, complicating the picture of the relationship between antibiotics and susceptibility to viruses.
The Search for Persisters
Amanda B. Keener | Aug 11, 2015 | 4 min read
Lyme disease–causing bacteria can outmaneuver antibiotics in vitro and manipulate the mouse immune system.
Suited to a T
Kelly Rae Chi | May 1, 2013 | 8 min read
Sorting out T-cell functional and phenotypic heterogeneity depends on studying single cells.
Making Things Grow: Insect Cells, Stem Cells, and Primary Cell Lines All Pose Challenges for Cell Culturists
Laura Defrancesco | Jun 21, 1998 | 5 min read
Date: June 22, 1998 Insect Cell Culture Media, Suppliers of Primary Cell Culture Media Advantages for Protein Expression Studies Since the mid-1950s cultures of insects--cockroaches, fruit flies, and leafhoppers, to name a few--have been the object of quiet study by physiologists and cell biologists. But along came genetic engineering and suddenly insect cultures have been put in the spotlight since they provide advantages over both bacterial and mammalian systems for recombinant protein prod
Top 10 Innovations 2013
The Scientist | Dec 1, 2013 | 10+ min read
The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.
Macro, Mini, Micro
Carina Storrs | Jan 1, 2013 | 7 min read
Clever microfluidic platforms take the study of protein-protein interactions to a new level.
Human Clinical Trials Begin For Cervical Cancer Vaccines
Steve Bunk | Oct 26, 1997 | 6 min read
Efforts are under way to develop a vaccine against one of the world's deadliest illnesses, cervical cancer. Along with a number of university research laboratories, at least a half-dozen biotechnology and pharmaceutical companies are beginning clinical trials or are in preclinical development of such drugs. Efficacy in humans remains to be firmly established, but if the vaccines progress to later-phase trials, challenging jobs for immunologists, microbiologists, and biochemists will multiply. "
Observers Praise AIDS Report But Foresee Problems In Implementation
Steven Benowitz | May 12, 1996 | 10 min read
Problems In Implementation LOUD AND CLEAR: Attorney Lynda Dee stresses the need for communication among the institutes. When a federally appointed panel announced in March the results of its 15-month-long review of the United States government's AIDS research program, AIDS activists as well as scientists cheered. The National Institutes of Health's AIDS Research Program Evaluation Working Group's recommendations largely called for scrapping what the group saw as outdated and ineffective polic

Run a Search

ADVERTISEMENT